​Eight Emerging Growth Stocks for Under a Buck

Joel Anderson  |

There’s a certain stigma that often goes along with a stock that’s share price is under a dollar. Being a penny stock can lead people to second guess even the best potential investment. However, fixating on share price can just as easily allow you to overlook a company that may be on fairly solid footing.

The reality is, there’s plenty of stocks with low share prices that also have the potential to take off. Certainly, they tend to fall into the small- and micro-cap range that brings with it a host of risks not associated with their large-cap brethren, but they also have a lot more potential for growth.

So, here’s a look at eight stocks that are currently trading under $1 a share. To weed out some of the real losers and avoid wasting all of our time (and money), we’ve run a screen to include only stocks trading an average of at least 75,000 shares a day, with an average rating of “buy” or better from the analysts covering them, and that have shown sales growth of at least 25% over the last five years.

Certainly, some of these are bound to be real losers, but the chance to take a nibble of a stock that really takes off can add needed diversification to your portfolio without requiring a huge initial investment.

So, without further ado…

Peregrine Pharmaceuticals (PPHM)

Market Cap: $105.51 million

Price: $0.42

Average Daily Volume: 818,132

Peregrine Pharmaceuticals is a biopharmaceutical company that develops monoclonal antibodies for the treatment of cancer. It also operated a separate segment in Avid, which provides manufacturing services to third parties on a fee-for-service basis.

Cumulus Media (CMLS)

Market Cap: $76.28 million

Price: $0.34

Average Daily Volume: 313,198

Cumulus Media owns and operates some 460 radio stations and 8,200 broadcast affiliates. The company also owns the NASH FM, which is a platform that provides country music content for FM radio stations nationwide.

Aoxing Pharmaceutical Company (AXN)

Market Cap: $44.26 million

Price: $0.56

Average Daily Volume: 84,781

Aoxing is a specialty pharmaceutical company that makes narcotics and pain management products as well as drug relief medications.

TearLab Corp (TEAR)

Market Cap: $38.19 million

Price: $0.72

Average Daily Volume: 91,669

TearLab is an in-vitro diagnostic company that specializes in eye care. It has commercialized its TearLab Osmolarity tear testing system, which can test a range of biomarkers at the point of care.

Amedica Corporation (AMDA)

Market Cap: $22.36 million

Price: $0.93

Average Daily Volume: 4.68 million

Amedica is a medical device company focused on biomaterials. The company develops a number of devices that build on its silicon nitride ceramic technology platform as well as wear- and corrosion-resistant implant components for hip and knee anthroplasty.

Rosetta Genomics (ROSG)

Market Cap: $18.87 million

Price: $0.92

Average Daily Volume: 117,561

Rosetta creates diagnostic tests based on various genomic markers including protein biomarkers, DNA, and microRNA.

WaferGen Bio-Systems (WGBS)

Market Cap: $16.4 million

Price: $0.86

Average Daily Volume: 346,389

WaferGen develops and manufactures genomic technology solutions for single-cell analysis and research. It’s also focused on marketing its WaferGen SmartChip System, an open format genetic analysis system.

Professional Diversity Network (IPDN)

Market Cap: $10.01 million

Price: $0.69

Average Daily Volume: 135,985

The Professional Diversity Network is focused on building professional networks focused on increasing the diversity of company workforces.

Prices and market caps accurate as of market close 9/21/2016. Screener performed on Finviz.com.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer.




Symbol Last Price Change % Change





















World Economic Forum at Davos 2019 - Ben Yablon Executive VP Salt Lending

Matt Bird sits down with Ben Yablon - Executive VP of Salt Lending - at the World Economic Forum in Davos January 2019